Loading...
Longevity Health Holdings Inc.
XAGE•NASDAQ
Healthcare
Biotechnology
$4.06
$-0.10(-2.40%)
Longevity Health Holdings Inc. (XAGE) Financial Performance & Statements
Review Longevity Health Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
4.19%
↑ 4.19%
Net Income Growth
32.87%
↑ 32.87%
Operating Cash Flow Growth
47.43%
↑ 47.43%
Operating Margin
-914.07%
↓ 914.07%
Gross Margin
55.97%
↑ 55.97%
Net Profit Margin
-1534.44%
↓ 1534.44%
ROE
246.61%
↑ 246.61%
ROIC
157.12%
↑ 157.12%
Longevity Health Holdings Inc. (XAGE) Financial Statements
Explore quarterly and annual reports for Longevity Health Holdings Inc. stock.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Cash & Cash Equivalents | $770047.00 | $157139.00 | $1.14M | $2.20M |
Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Cash & Short Term Investments | $770047.00 | $157139.00 | $1.14M | $2.20M |
Net Receivables | $396591.00 | $305934.00 | $219638.00 | $204559.00 |
Inventory | $1.38M | $108705.00 | $97890.00 | $113872.00 |
Other Current Assets | $246899.00 | $383776.00 | $430036.00 | $1.58M |
Total Current Assets | $2.79M | $955554.00 | $1.88M | $4.10M |
Property Plant & Equipment (Net) | $525553.00 | $498785.00 | $536187.00 | $910926.00 |
Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
Intangible Assets | $18504.00 | $19641.00 | $20778.00 | $21923.00 |
Goodwill & Intangible Assets | $18504.00 | $19641.00 | $20778.00 | $21923.00 |
Long Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
Other Non-Current Assets | $0.00 | $0.00 | $0.00 | $0.00 |
Total Non-Current Assets | $544057.00 | $518426.00 | $556965.00 | $932849.00 |
Total Assets | $3.34M | $1.47M | $2.44M | $5.03M |
Account Payables | $4.60M | $4.06M | $4.21M | $4.10M |
Short Term Debt | $232982.00 | $329056.00 | $449130.00 | $170789.00 |
Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Other Current Liabilities | $1.77M | $1.49M | $1.51M | $1.51M |
Total Current Liabilities | $6.60M | $5.88M | $6.17M | $5.78M |
Long Term Debt | $288615.00 | $309937.00 | $332573.00 | $627949.00 |
Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
Other Non-Current Liabilities | $254991.00 | $0.00 | $0.00 | $0.00 |
Total Non-Current Liabilities | $543606.00 | $309937.00 | $332573.00 | $627949.00 |
Capital Lease Obligations | $402188.00 | $397835.00 | $418736.00 | $777452.00 |
Total Liabilities | $7.14M | $6.19M | $6.51M | $6.41M |
Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
Common Stock | $100.00 | $2091.00 | $2091.00 | $2091.00 |
Retained Earnings | -$70.38M | -$68.87M | -$67.96M | -$65.08M |
Accumulated Other Comprehensive Income/Loss | $0.00 | $0.00 | $0.00 | $0.00 |
Total Stockholders Equity | -$3.81M | -$4.71M | -$4.06M | -$1.37M |
Total Equity | -$3.81M | -$4.71M | -$4.06M | -$1.37M |
Total Liabilities & Stockholders Equity | $3.34M | $1.47M | $2.44M | $5.03M |
Total Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Total Debt | $521597.00 | $638993.00 | $781703.00 | $798738.00 |
Net Debt | -$248450.00 | $481854.00 | -$355622.00 | -$1.40M |
Longevity Health Holdings Inc. (XAGE) Balance Sheet Analysis
Longevity Health Holdings Inc. (XAGE) manages its money wisely, with plenty of 47.43% and 32.87% to cover its bills. The company’s long-term debts are N/A, balanced by steady -1534.44%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan